Research and development incentives receivable, non-current
-
-
-
799
Restricted cash
1,703
1,703
1,704
1,705
Other non-current assets
3,238
2,942
1,200
1,200
Right-of-use asset - operating leases
3,068
3,270
3,498
3,692
Right-of-use asset - finance leases
31,773
32,380
32,987
33,594
Total assets
252,447
332,388
333,590
389,450
Accounts payable
4,261
6,671
5,647
6,404
Accrued expenses and other current liabilities
30,111
47,516
40,365
42,445
Operating lease liabilities, current
1,136
1,158
1,213
1,210
Finance lease liabilities, current
2,904
2,883
2,862
2,841
Total current liabilities
38,412
58,228
50,087
52,900
Operating lease liabilities, non-current
2,136
2,328
2,514
2,723
Finance lease liabilities, non-current
21,685
21,909
22,129
22,344
Long term debt, net of discount
84,114
83,308
47,628
47,206
Other liabilities, non-current
455
455
693
941
Total liabilities
146,802
166,228
123,051
126,114
Common stock, 0.001 par value 150,000,000 shares authorized as of june 30, 2026 and march 31, 2026 83,979,366 and 82,716,923 shares issued and outstanding as of june 30, 2026 and march 31, 2026, respectively
84
82
79
78
Additional paid-in capital
1,431,870
1,423,194
1,394,198
1,376,507
Accumulated deficit
-1,332,285
-1,262,519
-1,189,302
-1,118,372
Accumulated other comprehensive income
5,976
5,403
5,564
5,123
Total stockholders' equity
105,645
166,160
210,539
263,336
Total liabilities and stockholders' equity
252,447
332,388
333,590
389,450
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Time Plot
Show the time plot by selecting a row from the table.